Interleukin 2 News and Research

RSS

Targeting SARS-CoV-2 with Chaga mushroom – a natural antiviral compound

A new study examines the potential binding interaction of the beneficial components of Chaga mushroom with that of the SARS-CoV-2 RBD.

24 Oct 2021

Researchers identify mechanism behind insufficient treatment efficacy of psoriasis drugs

Interleukin-12 - a messenger molecule of immune cells - was long considered to trigger the development of psoriasis.

22 Oct 2021

Chemical substance may specifically inhibit both SARS-CoV-2 proteases and human protease

Researchers tested analogs of disulfiram on SARS-CoV-2 Mpro and PLpro to find more efficient and effective inhibitors that take advantage of disulfiram’s mechanism of binding to the cysteine residue.

22 Oct 2021

Influence of age on innate and adaptive immunity in COVID-19 patients

A new study investigates how age influences SARS-CoV-2 replication, innate and adaptive immune responses.

21 Oct 2021

Biomarker predicts severity of SARS-CoV-2 infection in patients

A new study investigates a biomarker to predict the severity of disease in patients infected with SARS-CoV-2.

20 Oct 2021

100% orange juice shows potential to help fight inflammation and oxidative stress

A new study suggests 100% orange juice has the potential to help fight inflammation and oxidative stress in adults, paving the way for further research on the topic.

19 Oct 2021

Novel approach to predict outcomes in COVID-19 patients

In a recent study, researchers have used the predictive power of chest CT scans and plasma cytokines to predict death and severity in COVID-19 patients.

19 Oct 2021

Common treatment for MIS-C patients likely works by depleting neutrophils

Intravenous immune globulin (IVIG) — a common treatment for multisystem inflammatory syndrome in children (MIS-C) — likely works by depleting immune cells called neutrophils, according to a recent study funded by the National Institutes of Health.

15 Oct 2021

Metabolic restoration as a therapeutic approach to promote natural immune protection against HIV

The human immunodeficiency virus (HIV-1) particularly attacks CD4 lymphocytes, a type of white blood cell considered to be the conductor of the immune system.

15 Oct 2021

Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine

The results of a phase 2 clinical trial featuring a SARS-CoV-2 recombinant protein vaccine developed by GlaxoSmithKline are reported, demonstrating a favorable immune response amongst both naïve and non-naïve adults with an acceptable safety profile.

15 Oct 2021

Study reveals a detrimental role of the immune system in Lewy body dementias

T-cells respond to buildups of alpha-synuclein, the aggregated protein clumps that are a feature of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease (PD), according to a Northwestern Medicine study published in Science.

14 Oct 2021

SARS-CoV-2 induces tissue immune memory

A new study reports that the SARS-CoV-2 induces protective tissue memory that includes both humoral and cellular elements to protect specific tissue sites.

14 Oct 2021

Study reveals the zoonotic potential of the rat Sialodacryoadenitis virus

A new review aimed to describe the current state of knowledge on Sialodacryoadenitis virus, along with its characteristics and potential zoonotic threat.

13 Oct 2021

New study finds SARS-CoV-2 causes retinal infection

Can coronavirus disease 2019 (COVID-19) affect the eye? New research suggests the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can enter the eye and infect photoreceptor and retinal ganglion cells. In addition, SARS-CoV-2 infection increases the expression of several inflammatory genes, including the cytokine interleukin 33 (IL33), which is linked to COVID-19 disease and retinal degeneration.

13 Oct 2021

Critical function of IL-7 in diagnosis, prognosis, and treatment of COVID-19 patients

In this review, researchers summarized the therapeutic and pathogenic role of IL-7 in patients with COVID-19 and examined the promising role of IL-7 as a vaccine adjuvant.

7 Oct 2021

Tiny bubbles show promise for reducing inflammation

Scientists hope that tiny sacs of material excreted by cells - so-called extracellular vesicles - can be used to deliver drugs inside the body. Researchers at Karolinska Institutet now show that these nano-bubbles can transport protein drugs that reduce inflammation caused by different diseases.

6 Oct 2021

Autoimmune disease drug helps prevent lung damage, death in mice with SARS-CoV-2 infection

In a new paper, researchers at the University of Illinois Chicago report that a drug approved for treating patients with autoimmune disease helped to prevent lung damage and death in mice infected with the SARS-CoV-2 virus, which causes COVID-19 in humans.

6 Oct 2021

Interleukin 2 News and Research

Targeting SARS-CoV-2 with Chaga mushroom – a natural antiviral compound

Researchers identify mechanism behind insufficient treatment efficacy of psoriasis drugs

Chemical substance may specifically inhibit both SARS-CoV-2 proteases and human protease

Influence of age on innate and adaptive immunity in COVID-19 patients

Biomarker predicts severity of SARS-CoV-2 infection in patients

100% orange juice shows potential to help fight inflammation and oxidative stress

Novel approach to predict outcomes in COVID-19 patients

Common treatment for MIS-C patients likely works by depleting neutrophils

Metabolic restoration as a therapeutic approach to promote natural immune protection against HIV

Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine

Study reveals a detrimental role of the immune system in Lewy body dementias

SARS-CoV-2 induces tissue immune memory

Study reveals the zoonotic potential of the rat Sialodacryoadenitis virus

New study finds SARS-CoV-2 causes retinal infection

Critical function of IL-7 in diagnosis, prognosis, and treatment of COVID-19 patients

Tiny bubbles show promise for reducing inflammation

Autoimmune disease drug helps prevent lung damage, death in mice with SARS-CoV-2 infection

A possible protective genetic polymorphism in COVID-19

J&J vaccine prevents SARS-CoV-2-induced thrombosis and inflammation in hamsters

How durable is the immune response generated from the BNT162b2 vaccine?

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News